Recent Progress in the Study of Zeaxanthin Dipalmitate
XIAO Jia,GAO Hao,ZHOU ZhengQun,WANG Ying,YAO XinSheng,SO Kwok-Fai
DOI: https://doi.org/10.1360/n972017-00262
2017-01-01
Chinese Science Bulletin (Chinese Version)
Abstract:Wolfberry is a traditional “affinal drug and diet”in Chinese and Eastern cultures, which is thought to nourish the liver,kidneys, and eyes for over one thousand years. Modern scientific studieshave proved that wolfberry and its derivatives could prevent and treata variety of diseases of the liver, gut, retina, neuron, and kidneys.However, due to its nature of mixture of a large number of constituents,it is quite difficult to delineate the major effective constituentand therapeutic mechanism responsible for those beneficial effects.This review will briefly introduce the recent progress of the botanicalcharacteristic, metabolism, structural classification and diseasetherapy of the major constituent—zeaxanthin dipalmitate (ZD)—andits derivatives from wolfberry carotenoids. In most published literatures,the health-promoting properties of wolfberry were investigated fromLycium barbarum polysaccharides, which were mixtures of mostly carbohydratesand a small part of pigments/proteins. Recently, we isolated wolfberryinto 5 parts, including polysaccharides, lycibarbars- permidines,polyphenols, phenylpropionoyl phenylethylamine, and carotenoids. Byusing several disease screening models, we found that the carotenoidextract of wolfberry could, at least partly, represent its diseaseprevention and therapy functions. Since ZD was shown to be the majorconstituent (~81.5%–87.5%) in total carotenoids of wolfberry,we considered that ZD could be a representative constituent of wolfberry.Thus, we firstly investigated the molecular mechanisms for the storage,synthesis, and degradation of ZD and other carotenoids during Lyciumbarbarum growth. Then we isolated and characterized all 15 carotenoidconstituents from wolfberry. It was found that free carotenoids werethe main pigments of immature wolfberry while esterified carotenoids(e.g. ZD) consisted most of the pigment materials in mature fruit.Thirdly, we reviewed the protective effects and possible mechanismsof ZD and its derivatives on liver diseases (e.g. acute liver failure,alcoholic liver injury, non-alcoholic fatty liver disease and viralhepatitis), stem cell injury and transplantation, cardiovascular disorders,eye diseases, and other digestive system syndromes, including tumors.In addition, possible future research directions and contents of ZDwill also be discussed, such as (i) can ZD represent most of the beneficialfunctions of wolfberry, or synergistic promoting effects are existedbetween ZD and other distinct constituents from wolfberry (e.g. lycibarbarspermidinesor polyphenols)? (ii) what is the optimal consumption dosage of ZDin daily life and is there any adverse effect of this kind of carotenoids?(iii) what is the exact metabolic pathways and tissue distributionafter ZD consumption? We strongly believe that delineation of thosequestions will definitive promote basic study, clinical application,and industrial development of wolfberry in the world.